John D. Davis

18.9k total citations
236 papers, 6.3k citations indexed

About

John D. Davis is a scholar working on Physiology, Surgery and Nutrition and Dietetics. According to data from OpenAlex, John D. Davis has authored 236 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Physiology, 29 papers in Surgery and 29 papers in Nutrition and Dietetics. Recurrent topics in John D. Davis's work include Biochemical Analysis and Sensing Techniques (28 papers), Regulation of Appetite and Obesity (26 papers) and Dermatology and Skin Diseases (17 papers). John D. Davis is often cited by papers focused on Biochemical Analysis and Sensing Techniques (28 papers), Regulation of Appetite and Obesity (26 papers) and Dermatology and Skin Diseases (17 papers). John D. Davis collaborates with scholars based in United States, United Kingdom and Belgium. John D. Davis's co-authors include Michael W. Levine, Deborah J. Brief, Gerard P. Smith, Constance S. Campbell, James R. Weeks, Prakash Sampath, Mohammed BenDebba, Thomas B. Ducker, María Claudia Pérez and David Wirtshafter and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

John D. Davis

229 papers receiving 5.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John D. Davis United States 42 1.4k 1.2k 1.1k 973 842 236 6.3k
D. C. Rao United States 63 720 0.5× 2.9k 2.5× 676 0.6× 1.2k 1.2× 2.4k 2.8× 391 14.4k
Thomas Klein United States 66 576 0.4× 1.5k 1.3× 406 0.4× 2.1k 2.2× 3.5k 4.2× 446 15.7k
Christopher M. Ryan United States 65 371 0.3× 2.2k 1.9× 381 0.3× 1.7k 1.8× 1.5k 1.8× 224 12.8k
John K. Young United States 37 800 0.6× 1.2k 1.0× 489 0.4× 281 0.3× 1.3k 1.6× 132 5.0k
Aldo E. Calogero Italy 60 541 0.4× 836 0.7× 506 0.4× 829 0.9× 2.4k 2.9× 502 13.5k
Tadataka Yamada United States 44 1.7k 1.3× 650 0.6× 1.8k 1.6× 2.6k 2.6× 2.7k 3.2× 166 8.2k
Michael A. Hill United States 55 279 0.2× 3.1k 2.6× 407 0.4× 1.7k 1.7× 3.7k 4.5× 259 12.0k
Louise D. McCullough United States 79 503 0.4× 2.2k 1.9× 354 0.3× 829 0.9× 5.6k 6.7× 378 20.6k
Manfred Rauh Germany 45 555 0.4× 1.2k 1.1× 545 0.5× 460 0.5× 1.8k 2.1× 189 6.8k
Pierre Déchelotte France 60 860 0.6× 2.6k 2.2× 1.9k 1.7× 1.8k 1.8× 3.5k 4.1× 477 13.1k

Countries citing papers authored by John D. Davis

Since Specialization
Citations

This map shows the geographic impact of John D. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Davis more than expected).

Fields of papers citing papers by John D. Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Davis. The network helps show where John D. Davis may publish in the future.

Co-authorship network of co-authors of John D. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of John D. Davis. A scholar is included among the top collaborators of John D. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. Davis. John D. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dingman, Robert, Jeanne Mendell, Katy C. Norman, et al.. (2025). Comparison of Model‐Predicted and Observed Evinacumab Pharmacokinetics and Efficacy in Children Aged < 5 Years With Homozygous Familial Hypercholesterolemia. CPT Pharmacometrics & Systems Pharmacology. 14(11). 1835–1847. 1 indexed citations
2.
Davis, John D., et al.. (2025). Exploring Completion Rates of the SNOT-22 Questionnaire. Annals of Otology Rhinology & Laryngology. 134(6). 459–462.
3.
DiMartino, Stephen J., Haitao Gao, Guillermo J. Valenzuela, et al.. (2025). Efficacy and safety of fasinumab in an NSAID-controlled study in patients with pain due to osteoarthritis of the knee or hip. BMC Musculoskeletal Disorders. 26(1). 192–192. 1 indexed citations
4.
Mendell, Jeanne, et al.. (2024). Population pharmacokinetic analyses of pozelimab in patients with CD55-deficient protein-losing enteropathy (CHAPLE disease). Journal of Pharmacokinetics and Pharmacodynamics. 51(6). 905–917. 2 indexed citations
5.
6.
DiMartino, Stephen J., Thomas J. Schnitzer, Haitao Gao, et al.. (2024). A phase III study to evaluate the long-term safety and efficacy of fasinumab in patients with pain due to osteoarthritis of the knee or hip. SHILAP Revista de lepidopterología. 6(4). 100533–100533. 2 indexed citations
7.
Trotter, Dinko González, Prodromos Parasoglou, Anita Boyapati, et al.. (2024). 34-OR: The Effect of Combined Activin A and Myostatin Blockade on Body Composition—A Phase 1 Trial. Diabetes. 73(Supplement_1). 2 indexed citations
8.
Kosloski, Matthew P., et al.. (2024). Dupilumab: Mechanism of action, clinical, and translational science. Clinical and Translational Science. 17(8). e13899–e13899. 36 indexed citations
9.
Wang, Yuhuan, et al.. (2023). Garetosmab in Fibrodysplasia Ossificans Progressiva: Clinical Pharmacology Results from the Phase 2 LUMINA‐1 Trial. The Journal of Clinical Pharmacology. 64(2). 264–274. 3 indexed citations
10.
Briggs, Emily, Mohamed Kamal, Matthew P. Kosloski, et al.. (2023). Integrated Exposure–Response of Dupilumab in Children, Adolescents, and Adults With Atopic Dermatitis Using Categorical and Continuous Efficacy Assessments: A Population Analysis. Pharmaceutical Research. 40(11). 2653–2666. 1 indexed citations
11.
Kamal, Mohamed, John D. Davis, Pavel Kovalenko, et al.. (2022). Pharmacokinetics, pharmacodynamics, and exposure–efficacy of dupilumab in adults with atopic dermatitis. Clinical and Translational Science. 15(10). 2342–2354. 4 indexed citations
12.
Cork, Michael J., Lawrence F. Eichenfield, Andrew Blauvelt, et al.. (2019). 605 Efficacy and safety of dupilumab in adolescent patients with moderate-to-severe atopic dermatitis. Journal of Investigative Dermatology. 139(5). S104–S104. 1 indexed citations
13.
14.
Gertz, Michael, et al.. (2008). Impact of permeability on in vitro predictions of intestinal availability in the QGut model. Drug Metabolism Reviews. 2 indexed citations
15.
Davis, John D., et al.. (2007). Massive uterovaginal prolapse in a young nulligravida with ascites: a case report.. PubMed. 52(8). 727–9. 2 indexed citations
16.
Vasiliou, Vasilis, John D. Davis, David W. Nees, et al.. (2007). Aldh3a1(-/-) Knockout Mice Reveal Novel Functions of Corneal Crystallins. Investigative Ophthalmology & Visual Science. 48(13). 4932–4932. 1 indexed citations
17.
Davis, John D., et al.. (2006). Orosensory stimulation is sufficient and postingestive negative feedback is not necessary for neuropeptide Y to increase sucrose intake. Physiology & Behavior. 87(4). 773–780. 11 indexed citations
18.
Davis, John D.. (2001). Prevention, diagnosis, and treatment of venous thromboembolic complications of gynecologic surgery. American Journal of Obstetrics and Gynecology. 184(4). 759–775. 28 indexed citations
19.
Sampath, Prakash, Mohammed BenDebba, John D. Davis, & Thomas B. Ducker. (2000). Outcome of Patients Treated for Cervical Myelopathy. Spine. 25(6). 670–676. 217 indexed citations
20.
Davis, John D. & Barbara Collins. (1978). Distention of the small intestine, satiety, and the control of food intake. American Journal of Clinical Nutrition. 31(10). S255–S258. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. C. Rao Breakdown of academic impact, for papers by Thomas Klein Breakdown of academic impact, for papers by Christopher M. Ryan Breakdown of academic impact, for papers by John K. Young Breakdown of academic impact, for papers by Aldo E. Calogero Breakdown of academic impact, for papers by Tadataka Yamada Breakdown of academic impact, for papers by Michael A. Hill Breakdown of academic impact, for papers by Louise D. McCullough Breakdown of academic impact, for papers by Manfred Rauh Breakdown of academic impact, for papers by Pierre Déchelotte
Rankless by CCL
2026